Striatal dopamine D₂-type receptor availability and peripheral 17β-estradiol

Area of Science:

• Neuroendocrinology
• Neuroimaging
• Human Physiology

Background:

• Rodent studies suggest estrogen influences dopamine function.
• A direct link between estrogen and human dopamine signaling remains unclear.
• Estrogen's role in human neurobiology requires further investigation.

Purpose of the Study:

• To investigate the relationship between 17β-estradiol levels and dopamine D2 receptor availability in the human brain.
• To assess if menstrual cycle-related estrogen fluctuations affect striatal dopamine D2 receptor availability.
• To bridge the gap between animal models and human neuroendocrine-estrogen-dopamine interactions.

Main Methods:

• Positron emission tomography (PET) with [18F]fallypride to measure striatal dopamine D2-type receptor availability.
• Radioimmunoassay to quantify serum 17β-estradiol levels.
• Recruitment of 16 women tested during low-estrogen (follicular) and high-estrogen (periovulatory) phases.

Main Results:

• No significant differences in dopamine D2-type receptor availability were observed in the whole striatum or its subregions (caudate, putamen, accumbens).
• Findings were consistent across both high-estrogen and low-estrogen phases of the menstrual cycle.
• Peripheral 17β-estradiol levels did not correlate with striatal dopamine D2 receptor availability.

Conclusions:

• Circulating estrogen levels do not appear to modulate dopamine D2-type receptor availability in the human striatum.
• While D2 receptor availability is unaffected, other aspects of dopaminergic function might still be influenced by estrogen.
• This study provides crucial human data on the estrogen-dopamine interaction, diverging from some rodent model implications.